Interferon regulatory factors: The next generation

Gene

Volumn 237, Issue 1, 1999, Pages 1-14

  Mamane, Yael ^a   Heylbroeck, Christophe ^a   Génin, Pierre ^a   Algarté, Michele ^a   Servant, Marc J ^a   Lepage, Cécile ^a   Deluca, Carmela ^a   Kwon, Hakju ^a   Lin, Rongtuan ^a   Hiscott, John ^a  

^a NONE

Author keywords

Immune regulation; Interferon; Interferon regulatory factors; Transcription factor; Virus infection

Indexed keywords

INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR 5; INTERFERON REGULATORY FACTOR 6; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; BINDING SITE; CELL GROWTH; DNA BINDING; GENE EXPRESSION; GENE INDUCTION; HUMAN; IMMUNE STATUS; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON REGULATORY FACTORS; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; INTERFERONS; LEUKEMIA, T-CELL; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; REPRESSOR PROTEINS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 0032841028     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00262-0     Document Type: Review

References (100)

1. Au W.-C., Moore P.A., Lowther W., Juang Y.-T., Pitha P.M. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. U. S. A. 92:1995;11 657-11 661.
2. Au W.C., Moore P.A., LaFleur D.W., Tombal B., Pitha P.M. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J. Biol. Chem. 273:1998;29 210-29 217.
3. Aziz F., van Wijnen A.J., Stein J.L., Stein G.S. HINF-D influences the timing of IRF-2-dependent cell cycle activation of human histone H4 gene transcription at the G1/S phase transition. J. Cell. Physiol. 177:1998;453-464.
4. Bellingham J., Gregory-Evans K., Gregory-Evans C.Y. Mapping of human interferon regulatory factor 3 (IRF3) to chromosome 19q13.3-13.4 by an intragenic polymorphic marker. Ann. Hum. Genet. 62:1998;231-234.
5. Blanch V.J., Piskurich J., Kaetzel C.S. Coordinate regulation of IFN regulatory Factor-1 and polymeric Ig receptor by proinflammatory cytokines. J. Immunol. 162:1999;1232-1235.
6. Bluyssen H.A.R., Durbin J.E., Levy D.E. ISGF3γ p48, a specificity switch for interferon activated transcription factors. Cyt. Growth Fact. Rev. 7:1996;11-17.
7. Braganca J., Civas A. Type I interferon gene expression: differential expression of IFN-A genes induced by viruses and double-stranded RNA. Biochimie. 80:1998;673-687.
8. Bragança J., Génin P., Bandu M.-T., Darracq N., Vignal M., Cassé C., Doly J., Civas A. Synergism between multiple virus-induced-factor-binding elements involved in the differential expression of IFN-A genes. J. Biol. Chem. 272:1997;22 154-22 162.
9. Brass A., Kehrli E., Eisenbeis C., Storb U., Singh H. Pip, a lymphoid restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev. 10:1996;2335-2347.
10. Brass A.L, Zhu A.Q., Singh H. Assembly requirements of PU.1/Pip (IRF-4) activator complexes - inhibiting function in vivo using fused dimers. EMBO J. 18:1999;977-991.
11. Burysek L., Yeow W.S., Pitha P.M. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J. Hum. Virol. 2:1999;19-32.
12. Crepieux P., Coll J., Stehelin D. The Ets family of proteins: weak modulators of gene expression in quest for transcriptional partners. Crit. Rev. Oncogen. 5:1994;615-638.
13. Daly C., Reich N.C. Double-stranded RNA activates novel factors that bind to the interferon stimulated response element. Mol. Cell. Biol. 13:1993;3756-3764.
14. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1994;1415-1421.
15. Driggers P.H., Ennist D.L., Gleason S.L., Mak W.-H., Marks M.S., Levi B.-Z., Flanagan J.R., Appella E., Ozato K. An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA. 87:1990;3743-3747.
16. Eisenbeis C.F., Singh H., Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1995;1377-1387.
17. Eklund E.A., Javala A., Kakar R. PU.1, IRF-1, and ICSBP cooperate to increase gp91phox expression. J. Biol. Chem. 273:1998;13 957-13 965.
18. Escalante C.R., Yie J., Thanos D., Aggarwal A.K. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature. 391:1998;103-106.
19. Falvo J.V., Thanos D., Maniatis T. Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell. 83:1995;1101-1111.
20. Flowers C.C, Flowers S.P., Nabel G. Kaposi's sarcoma associated herpesvirus viral IRF confers resistance to the antiproliferative effect of IFNα Mol. Med. 4:1998;402-412.
21. Fujita T., Sakakibara J., Sudo Y., Miyamoto M., Kimura Y., Taniguchi T. Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-β gene regulatory elements. EMBO J. 7:1988;3397-3405.
22. Fujita T., Kimura Y., Miyamoto M., Barsoumian E.L., Taniguchi T. Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor IRF-1. Nature. 337:1989;270-272.
23. Furui J., Uegaki K., Yamazaki T., Shirakawa M., Swindells M.B., Harada H., Taniguchi T., Kyogoku Y. Solution structure of the IRF-2 DNA-binding domain: a novel subgroup of the winged helix-turn-helix family. Structure. 6:1998;491-500.
24. Gonda T. The c-Myb oncoprotein. Int. J. Biochem. Cell. Biol. 30:1998;517-551.
25. Génin P., Bragança J., Darracq N., Doly J., Civas A. A novel PRD I and TG binding activity involved in virus-induced transcription of IFN-A genes. Nucl Acid Res. 23:1995;5055-5063.
26. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:1989;729-739.
27. Harada H., Willison K., Sakakibara J., Miyamoto M., Fujita T., Taniguchi T. Absence of type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell. 63:1990;903-913.
28. Harada H., Kitagawa M., Tanaka N., Yamamoto H., Harada K., Ishihara M., Taniguchi T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science. 259:1993;971-974.
29. Harada H., Matsumoto M., Sato M., Kashiwazaki Y., Kimura T., Kitagawa M., Yokochi T., Tan R.S.-P., Takasugi T., Kadokawa Y., Schindler C., Schreiber R.D., Noguchi S., Taniguchi T. Regulation of IFN-α/β genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-α/β Genes Cells. 1:1996;995-1005.
30. Hiscott J., Petropoulos L., Lacoste J. Molecular interActions between HTLV-1 Tax protein and the NF-κB/IκB transcription complex. Virology. 214:1995;3-11.
31. Hiscott J., Pitha P., Génin P., Nguyen H., Heylbroeck C., Mamane Y., Algarté M., Lin R. Triggering the interferon response: the role of IRF-3 transcription factor. J. Interferon Cytokine Res. 19:1999;1-13.
32. Holtschke T., Löhler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., Lou J., Knobeloch K.-P., Gabriele L., Waring J.F., Bachmann M.F., Zingernagel R.M., Morse H.C. III, Ozato K., Horak I. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 87:1996;307-317.
33. Hombach J., Pircher H., Tonegawa S., Zinkernagel R.M. (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal of a virus protein. J. Exp. Med. 182:1995;1615-1619.
34. Iida S., Rao P.H., Butler M., Corradini P., Boccadoro M., Klein B., Chaganti R.S.K., Dalla-Favera R. Deregulation of MUM1/IRF-4 by chromosomal translocation in multiple myeloma. Nat. Genet. 17:1997;226-230.
35. Jesse T.L., LaChance R., Iademarco M.F., Dean D.C. IRF-2 is a transcriptional activator in muscle where it regulates expression of vascular cell adhesion molecule-1. J. Cell Biol. 140:1998;1265-1276.
36. Juang Y.T., Lowther W., Kellum M., Au W.C., Lin R., Hiscott J., Pitha P.M. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factory-3. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9837-9842.
37. Kim T.K., Maniatis T. The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome. Mol. Cell. 1:1998;119-129.
38. Kimura T., Kadokawa Y., Harada H., Matsumoto M., Sato M., Kashiwazaki Y., Tarutani M., Tan R.S.-P., Takasugi T., Matsuyama T., Mak T.M., Noguchi S., Taniguchi T. Essential and non-redundant roles of p48 (ISGF3γ) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells. 1:1996;115-124.
39. Kusumoto M., Fujii Y., Tsukuda Y., Ohira T., Kyougoku Y., Taniguchi T., Hakoshima T. Crystallographic characterization of the DNA-binding domain of IRF-2 complexed to DNA. J. Struct. Biol. 121:1998;363-366.
40. Leverson J.D., Ness S.A. Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism. Mol. Cell. 1:1998;203-211.
41. Levy D.E. Interferon induction of gene expression through the Jak-Stat pathway. Sem. Virol. 6:1995;181-190.
42. Li M., Lee H., Guo J., Neipel F., Fleckenstein B., Ozato K., Jung J.U. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J. Virol. 72:1998;5433-5440.
43. Lin R., Hiscott J. A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity. Mol. Cell. Biochem. 191:1999;169-180.
44. Lin R., Heylbroeck C., Pitha P.M., Hiscott J. Virus dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential and proteasome mediated degradation. Mol. Cell. Biol. 18:1998;2986-2996.
45. Lin R., Heylbroeck C., Genin P., Pitha P., Hiscott J. Essential role of IRF-3 in direct activation of RANTES gene transcription. Mol. Cell. Biol. 19:1999;959-966.
46. Lin R., Mamane Y., Hiscott J. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol. Cell. Biol. 19:1999;2465-2474.
47. Marie I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:1998;6660-6669.
48. Marks A.R. Cellular functions of immunophilins. Physiol. Rev. 76:1996;631-649.
49. Masumi A., Wang I.M., Lefebvre B., Yang X.J., Nakatani Y., Ozato K. The histone acetylase PCAF is phobol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol. Cell. Biol. 19:1999;1810-1820.
50. Matsuyama T., Kimura T., Kitagawa M., Watanabe N., Kundig T., Amakawa R., Kishihara K., Wakeham A., Potter J., Furlonger C., Narendran A., Suzuki H., Ohashi P., Paige C., Taniguchi T., Mak T. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN induction and aberrant lymphocyte development. Cell. 75:1993;83-97.
51. Matsuyama T., Grossman A., Mittrücker H.-W., Siderovski D.P., Kiefer F., Kawakami T., Richardson C.D., Taniguchi T., Yoshinaga S.K., Mak T.W. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23:(12):1995;2127-2136.
52. McElliot D.L., Phillips J.A., Stillman C.A., Koch R.J., Moiser D.E., Hobbs M.V. CD4+ T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis. J. Immunol. 159:1997;4180-4186.
53. Merika M., Williams A.J., Chen G., Collins T., Thanos D. Recruitment of CBP/p300 by the IFNβ enhanceosome is required for synergistic activation of transcription. Mol. Cell. 1:1998;277-287.
54. Mittrücker H.-W., Matsuyama T., Grossman A., Küdig T.M., Potter J., Shahinian A., Wakeham A., Patterson B., Ohashi P.S., Mak T.W. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 275:1997;540-543.
55. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to the IFN-β gene regulatory elements. Cell. 54:1988;903-913.
56. Moore P.S., Boshoff C., Weiss R.A., Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 274:1996;1739-1744.
57. Nagulapalli S., Atchison M.L. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol. Cell. Biol. 18:1998;4639-4650.
58. Navarro L., Mowen K., Rodems S., Weaver B., Reich N., Spector D., David M. Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol. Cell. Biol. 18:1998;3796-3802.
59. Nelson N., Marks M.S., Driggers P.H., Ozato K. Interferon consensus sequence binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell. Biol. 13:1993;588-599.
60. Nguyen H., Hiscott J., Pitha P.M. The growing family of IRF transcription factors. Cyt. Growth Fact. Rev. 8:1997;293-312.
61. Nonkwelo C., Ruf I.K., Sample J. Interferon-independent and induced regulation of Epstein-Barr Virus EBNA-1 gene transcription in Burkitt lymphoma. J. Virol. 71:1997;6887-6897.
62. Nozawa H., Oda E., Tamura G., Maesawa C., Muto T., Taniguchi T., Tanaka N. Functional inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer. Int. J. Cancer. 77:1998;522-527.
63. Ogasawara K., Hida S., Azimi N., Tagaya Y., Sato T., Yokochi-Fukuda T., Waldmann T.A., Taniguchi T., Taki S. Requirements for IRF-1 in the microenvironment supporting development of natural killer cells. Nature. 391:1998;700-703.
64. Ohteki T., Yoshida H., Matsuyama T., Duncan G.S., Mak T.W., Ohashi P.S. The transcription factor interferon regulatory factor-1 is important during the maturation of natural killer cells 1.1+T cell receptor alpha/beta+(NK1+T) cells, natural killer cells and intestinal intraepithelial T cells. J. Exp. Med. 187:1998;967-972.
65. Ortiz M.A., Light J., Maki R.A., Assa-Munti N. Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2740-2745.
66. Parekh B.S., Maniatis T. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-β promoter. Mol. Cell. 3:1999;125-129.
67. Park K.C., Shimizu K., Hayakawa T., Tanaka N. Regulation of interferon responses in medulloblastoma cells by IRF-1 and -2. Brit. J. Cancer. 77:1998;2081-2087.
68. Penninger J.M., Mak T.W. Thymocyte selection in Vav and IRF-1 gene-defecient mice. Immunol. Rev. 165:1998;149-166.
69. Ronco L., Karpova A., Vidal M., Howley P. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:1998;2061-2072.
70. Rubinstein Y.R., Proctor K.N., Bergel M., Murphy B., Johnson A.C. IRF-1 is a major regulator of epidermal growth factor receptor gene expression. FEBS Lett. 431:1998;268-272.
71. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., Moore P. Nucleotide sequence of the kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U. S. A. 93:1996;14 862-14 867.
72. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441:1998;106-110.
73. Schafer S.L., Lin R., Moore P.A., Hiscott J., Pitha P.M. Regulation of type 1 interferon gene expression by interferon regulatory factor 3. J. Biol. Chem. 273:1998;2714-2720.
74. Schmidt M., Nagel S., Proba J., Thiede C., Ritter M., Waring J.F., Rosenbaauer F., Huhn D., Wittig B., Horak I., Neubauer A. Lack of ICSBP transcripts in human myeloid leukemias. Blood. 91:1998;22-29.
75. Sharf R., Meraro D., Azriel A., Thornton A.M., Ozato K., Petricoin E.F., Larner A.C., Schaper F., Hauser H., Levi B.-Z. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J. Biol. Chem. 272:1997;9785-9792.
76. Stark G.R., Kerr I.M., Williams B.R.G., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
77. Takeuchi R., Tsutsumi H., Osaki M., Haseyama K., Mizue N., Chiba S. Respiratory syncytial virus infection of human alveolar epithelial cells enhances IRF-1 and Interleukin-1β-converting enzyme but does not induce apoptosis. J. Virol. 72:1998;4498-4502.
78. Takeuchi R., Tsutsumi H., Osaki M., Sone S., Imai S., Chiba S. Respiratory syncytial virus infection of neonatal monocytes stimulates synthesis of IRF-1 and ICE and secretion of IL-1β J. Virol. 72:1998;837-840.
79. Tamura T., Ishihara M., Lamphier M.S., Tanaka N., Oishi I., Aizawa S., Matsuyama T., Mak T.W., Taki S., Taniguchi T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T-lymphocytes. Nature. 376:1995;596-599.
80. Tanaka N., Kawakami T., Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13:1993;4531-4538.
81. Tanaka N., Ishihara M., Kitagawa M., Harada H., Kimura T., Matsuyama T., Lamphier M.S., Aizawa S., Mak T.W., Taniguchi T. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 77:1994;829-839.
82. Tanaka N., Ishihara M., Taniguchi T. Suppression of c-myc or fos-B-induced cell transformation by the transcription factor IRF-1. Cancer Lett. 83:1994;191-196.
83. Taniguchi T., Lamphier M.S., Tanaka N. IRF-1: the transcription factor linking the interferon response and oncogenesis. Biochim. Biophys. Acta Rev. Cancer. 1333:1997;M9-M17.
84. Thanos D., Maniatis T. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell. 83:1995;1091-1100.
85. Van Kaer L., Ashton-Rickardt P.G., Eichelberg M., Gaczynska M., Nagashima K., Rock K.L., Goldberg A.L., Doherty P.C., Tonegawa S. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity. 1:1994;533-541.
86. Vaughan P.S., Aziz F., van Wijnen A.J., Wu S., Harada H., Taniguchi T., Soprano K.J., Stein J.L., Stein G.S. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature. 377:1995;362-365.
87. Vaughan P.S., Van Der Meijden C., Aziz F., Harada H., Taniguchi T., Van Wijnen A., Stein J.L., Stein G.S. Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2. J. Biol. Chem. 273:1998;194-199.
88. Vaughan P.S., Van Wijnen A.J., Stein J.L., Stein G.S. Interferon regulatory factors: growth control and histone gene regulation - it's not just interferon anymore. J. Mol. Med. 75:1997;348-359.
89. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. U. S. A. 93:1996;2239-2244.
90. Wathelet M.G., Lin C.H., Parakh B.S., Ronco L.V., Howley P.M., Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell. 1:1998;507-518.
91. Weaver B.K., Kumar K.P., Reich N.C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18:1998;1359-1368.
92. Weisz A., Marx P., Sharf R., Appella E., Driggers P.H., Ozato K., Levi B.-Z. Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J. Biol. Chem. 267:1992;25 589-25 596.
93. -/- mice. Immunity. 5:1996;365-376.
94. Willman C.L., Sever C.E., Pallavicini M.G., Harada H., Tanaka N., Slovak M.L., Yamamoto H., Harada K., Meeker T.C., List A.F., Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasias. Science. 259:1993;968-971.
95. Wu C.Y., Maeda H., Contursi C., Ozato K., Seder R.A. Differential requirement of ICSBP for the production of IL-12 and induction of Th1-type cells in response to IFNγ J. Immunol. 162:1999;807-812.
96. Yamagata T., Nishida J., Tanaka T., Sakai R., Mitani K., Yoshida M., Taniguchi T., Yazaki Y., Hirai H. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell. Biol. 16:1996;1283-1294.
97. Yoneyama M., Suhara W., Fukuhara Y., Sato M., Ozato K., Fujita T. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. 120:1996;160-169.
98. Yoneyama M., Suhara W., Fukuhara Y., Fukada M., Nishida E., Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17:1998;1087-1095.
99. Zhang L., Pagano J.S. IRF-7, a new interferon regulatory factor associated with Epstein Barr Virus latency. Mol. Cell. Biol. 17:1997;5748-5757.
100. Zimring J.C., Goodbourn S., Offerman M.K. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J. Virol. 72:1998;701-707.